Crossmark

Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy

Published Online: 2023-07-10

Published Print: 2023-11

Authors

Lautenschlaeger, S. https://orcid.org/0000-0001-9619-1427
Dumke, C.

Exeli, L.

Hauswald, H.

Engenhart-Cabillic, R.

Eberle, F.
License Information

Text and Data Mining valid from 2023-07-10

Version of Record valid from 2023-07-10
More Information

Article History

Received: 2 February 2023

Accepted: 4 June 2023

First Online: 10 July 2023

Conflict of interest

: S. Lautenschlaeger, C. Dumke, L. Exeli, H. Hauswald, R. Engenhart-Cabillic and F. Eberle declare that they have no competing interests.

Document is current